Berberine is a potent, plant-derived isoquinoline alkaloid that has gained significant attention in metabolic research. Clinical evidence demonstrates its ability to consistently lower fasting blood glucose, reduce HbA1c, and improve lipid profiles by lowering LDL cholesterol and triglycerides. It primarily works by activating AMP-activated protein kinase (AMPK) and upregulating hepatic LDL receptors, offering metabolic benefits whose magnitude is frequently compared to standard pharmacological therapies like metformin.
This is a preclinical study involving in vivo mouse models and in vitro cellular assays investigating mechanistic pathways for hepatic lipid accumulation.
